CIK 0001841387 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Candel Therapeutics, Inc.
Sign in to watch- Ticker
- CADL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522214851
- Phone
- 617-916-5445
- Business address
- 117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
- 4 Open-market sale Chief Scientific Officer sold 14,051 shares at $6.47 ($90,947)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Technology Officer sold 13,330 shares at $5.97 ($79,625)
- 4 Open-market sale Chief Executive Officer sold 20,293 shares at $5.97 ($121,218)
- 4 Open-market sale See Remarks sold 8,897 shares at $5.97 ($53,145)
- 4 Open-market sale Chief Medical Officer sold 9,769 shares at $5.97 ($58,354)
- 4 Open-market sale Chief Scientific Officer sold 12,645 shares at $5.97 ($75,534)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 11 of 22 · 422 filings